Clinical Trial Update: Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating induction-concurrent chemoradiotherapy and/or accelerated fractionation in nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Hong Kong Nasopharyngeal Cancer Study Group Limited | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: COMPLETED